✦ LIBER ✦

P0021 Gemcitabine–docetaxel versus cisplatin–gemcitabine as first-line therapy in patients with metastatic non-small-cell lung cancer

✍ Scribed by Al-Gizawy, S.M.; Mostafa, H.G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine and cisplatin as a first lin

✍ Pes̆ek, M; Eliasová, B; C̆ertíková, G 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Docetaxel/gemcitabine or cisplatin/gemci

✍ D. Binder; H. Schweisfurth; C. Grah; C. Schäper; B. Temmesfeld-Wollbrück; G. Sie 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 340 KB

A phase II randomized trial of gemcitabi

✍ Joaquín Casal Rubio; S. Vázquez; F. Vázquez; M. Amenedo; J. L. Fírvida; J. R. Me 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 255 KB

P-457 Docetaxel/gemcitabine vs. cisplati

✍ Binder, D.; Schweisfurth, H.; Grah, C.; Schäper, C.; Temmesfeld-Wollbrück, B.; S 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 276 KB

Economic evaluation of docetaxel/gemcita

✍ Maniadakis, N.; Fragoulakis, V.; Pallis, A.; Prezerakos, P.; Georgoulias, V. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 580 KB

Phase II trial of weekly docetaxel and g

✍ Sujith Kalmadi; Giles McNeill; Mellar Davis; David Peereboom; David Adelstein; T 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 68 KB